Uncategorized

Axid (nizatidine) drug recalled due to presence of NDMA

Posted on

The Pendopharm Division of Pharmascience Inc. is recalling two lots of Axid (nizatidine) from the Canadian market, as they contain a nitrosamine impurity, N-nitrosodimethylamine (NDMA), which is a probable human carcinogen, at the maximum acceptable limit. Axid is a prescription drug used to treat ulcers in the stomach and intestine, as well as heartburn.